Ryan Michael
About Ryan Michael
Ryan Michael serves as the Vice President of Product at Slice, having transitioned to this role in 2024 after two years as Senior Director of Product, B2B. Previously, he held various positions at Google, including Head of Product Operations and Growth, and has a background in business development and product management.
Current Role at Slice
Ryan Michael serves as the Vice President of Product at Slice, a position he has held since 2024. In this role, he is responsible for overseeing product strategy and development, focusing on enhancing the company's offerings in the food delivery sector. His leadership aims to drive innovation and improve user experience within the platform.
Previous Experience at Google
Ryan Michael has an extensive background at Google, where he held several key positions. He was the Head of Product Operations and Growth for Maps (SMB) from 2018 to 2021. Following this, he served as the Head of Product Operations and Growth for Commerce and Maps from 2021 to 2022. His tenure at Google also included roles as Business Development and StratOps Manager for Emerging Markets from 2013 to 2016, and as Associate Account Manager in the US Online Partnerships Group from 2012 to 2013.
Education and Academic Background
Ryan Michael earned a Bachelor of Science degree from Cornell University. His education provided a foundation for his career in product management and operations, equipping him with the skills necessary to excel in various roles within the tech industry.
Career Progression at Slice
Before becoming Vice President of Product at Slice, Ryan Michael was the Senior Director of Product for B2B from 2022 to 2024. In this role, he focused on developing product strategies that catered to business clients, enhancing Slice's market position in the B2B sector.
Experience at Pfizer
Prior to his time at Google, Ryan Michael worked at Pfizer as a Territory Product Manager from 2010 to 2012. In this role, he managed product strategies and sales initiatives, contributing to the company's growth in the pharmaceutical sector.